Grown Rogue International (GRUSF) Cash from Financing Activities (2013 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Cash from Financing Activities of $2.7 million in Q1 2026, up 100.0% quarter-over-quarter from -$10136.9 billion in Q4 2025, and down 41.3% on a YoY basis from $4.5 million in Q1 2025.

Grown Rogue International (GRUSF) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Grown Rogue International's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at $2.7 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 41.3% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at -$10136.9 billion (down 299677217.61% YoY), while the FY2025 annual figure was $9.8 million, up 117.4% from the prior year.
  • Cash from Financing Activities was $2.7 million for Q1 2026 at Grown Rogue International, up from -$10136.9 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $4.5 million in Q1 2025 to a low of -$10136.9 billion in Q4 2025.
  • Historically, Cash from Financing Activities has averaged -$921.5 billion across 5 years, with a median of -$200531.9 in 2024.
  • Biggest YoY gain for Cash from Financing Activities was 54.82% in 2025; the steepest drop was 3604482049.28% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$558849.0 in 2022, then surged by 543.08% to $2.5 million in 2023, then tumbled by 111.36% to -$281230.6 in 2024, then tumbled by 3604482049.28% to -$10136.9 billion in 2025, then jumped by 100.0% to $2.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at $2.7 million (Q1 2026), -$10136.9 billion (Q4 2025), and -$308664.9 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Grown Rogue International - - 3.96 Mn 2.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.67 Mn
Mar 31, 2026 2.67 Mn
Dec 31, 2025 -10,136.91 Bn
Dec 31, 2025 -10,136.91 Bn
Jun 30, 2025 -308,664.89
Jun 30, 2025 -308,664.89
Mar 31, 2025 4.55 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 -281,230.64
Dec 31, 2024 -281,230.64
Sep 30, 2024 -200,531.89
Sep 30, 2024 -200,531.89
Jun 30, 2024 -683,206.97
Jun 30, 2024 -683,206.97
Oct 31, 2023 2.48 Mn
Oct 31, 2023 2.48 Mn
Jul 31, 2023 3.08 Mn
Jul 31, 2023 3.08 Mn
Apr 30, 2022 -558,849.00
Apr 30, 2022 -558,849.00